Meta-Analysis of the Safety of 5-HT 3 Antagonists with Dexamethasone or Droperidol for Prevention of PONV

Abstract

Spanish

French

Background:

Antiemetic guidelines recommend a combination of serotonin (5-HT₃) with a second agent such as droperidol or dexamethasone. Physicians have been reluctant to employ these guidelines due to concerns over the black-box warning of droperidol and safety concerns with a steroid.

Objective:

To assess the safety profiles of 5-HT₃ receptor antagonist (5-HT₃RA) monotherapy and combination therapy with a steroid or droperidol for prophylaxis of postoperative nausea and vomiting (PONV).

Methods:

A MEDLINE search of English-language reports of randomized controlled trials (RCTs) was conducted (1966–September 2005) using the key terms 5-HT₃, granisetron, ondansetron, dolasetron, tropisetron, PONV, postoperative, vomiting, emesis, and nausea. RCTs with treatment arms comparing 5-HT₃RA monotherapy (granisetron, ondansetron, dolasetron, or tropisetron) with dexamethasone or droperidol or 5-HT₃RA combinations and providing incidence data on adverse events were identified and reviewed. Within-study odds ratios with 95% confidence intervals were calculated to determine the incidence rates of all adverse events in RCTs using 5-HT₃RA monotherapy and combination therapies. Overall effect sizes for frequently reported adverse events were estimated by pooling ORs using fixed- and random-effect models.

Results:

Pooled ORs (OR_pooled) for adverse events with 5-HT3RA/dexamethasone versus 5-HT₃RA for PONV prophylaxis were not significant for any reported adverse events or the overall incidence of adverse events; 5-HT₃RA/droperidol versus 5-HT₃RA was significant only for decreased headache incidence (fixed model: OR_pooled 0.35; 95% CI 0.18 to 0.69). The OR_pooled for 5-HT₃RA/dexamethasone versus dexamethasone was not significant for any reported adverse events except headaches (fixed model OR_pooled 1.75; 95% CI 1.01 to 3.03), none of which was serious. OR_pooled for 5-HT₃RA/droperidol versus droperidol was not significant for any reported adverse events. Avascular necrosis, occult infection, and delayed wound healing were not observed with either combination therapy. Cardiac abnormalities were observed with 5-HT₃RA/droperidol therapy.

Conclusions:

This meta-analysis indicates that either therapy has a safety profile similar to that of dexamethasone, droperidol, or 5-HT₃RA.

Keywords

dexamethasone dolasetron droperidol granisetron ondansetron PONV

Get full access to this article

View all access options for this article.

References

Habib

, Gan

. Pharmacotherapy of postoperative nausea and vomiting. Expert Opin Pharmacother 2003;4:457–73.

Gan

, Meyer

, Apfel

. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003;97:62–71.

FDA strengthens warnings for droperidol (talk paper, T01-62). Rockville, MD: US Food and Drug Administration, December 5, 2001.

Loewen

, Marra

, Zed

. 5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting. Can J Anaesth 2000;47:1008–18.

Henzi

, Walder

, Tramer

. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2000;90:186–94.

Eberhart

, Morin

, Georgieff

Dexamethasone for prophylaxis of postoperative nausea and vomiting. A meta-analysis of randomized controlled studies. Anaesthesist 2000;49:713–20.

Apfel

, Korttila

, Abdalla

A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004;350:2441–51.

Habib

, El Moalem

, Gan

. The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials. Can J Anaesth 2004;51:311–9.

Scuderi

, James

, Harris

, Mims

III . Multimodal antiemetic management prevents early postoperative vomiting after outpatient laparoscopy. Anesth Analg 2000;91:1408–14.

10.

Habib

, Gan

. Food and Drug Administration black box warning on the perioperative use of droperidol: a review of the cases. Anesth Analg 2003;96:1377–9.

11.

Charbit

, Albaladejo

, Funck-Brentano

, Legrand

, Samain

, Marty

Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology 2005;102:1094–100.

12.

Kasinath

, Malak

, Tetzlaff

Atrial fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting: a case report. Can J Anaesth 2003;50:229–31.

13.

Gogas

, Fennelly

Avascular necrosis following extensive chemotherapy and dexamethasone treatment in a patient with advanced ovarian cancer: case report and review of the literature. Gynecol Oncol 1996;63:379–81.

14.

Fast

, Alon

, Weiss

, Zer-Aviv

. Avascular necrosis of bone following short-term dexamethasone therapy for brain edema. Case report. J Neurosurg 1984;61:983–5.

15.

McCluskey

, Gutteridge

. Avascular necrosis of bone after high doses of dexamethasone during neurosurgery. Br Med J (Clin Res Ed) 1982;284:333–4.

16.

Product information. Decadron phosphate (dexamethasone sodium phosphate) injection prescribing information. Whitehouse Station, NJ: Merck & Co., 2001.

17.

Kranke

, Apfel

, Greim

, Roewer

Methodological problems arising from “serial publishing” on the effectiveness of granisetron in PONV. Br J Anaesth 1999;82:481–3.

18.

Kranke

, Apfel

, Roewer

, Fujii

Reported data on granisetron and postoperative nausea and vomiting by Fujii et al. are incredibly nice! Anesth Analg 2000;90:1004–7.

19.

Apfel

, Kranke

, Greim

, Roewer

Non-systematic serial publishing is not appropriate and ethically questionable. Acta Anaesthesiol Scand 1999;43:486–7.

20.

Kranke

, Apfel

, Eberhart

, Georgieff

, Roewer

The influence of a dominating centre on a quantitative systematic review of granisetron for preventing postoperative nausea and vomiting. Acta Anaesthesiol Scand 2001;45:659–70.

21.

Eberhart

, Morin

, Hoerle

, Wulf

, Geldner

Droperidol and dolasetron alone or in combination for prevention of postoperative nausea and vomiting after vitrectomy. Ophthalmology 2004;111:1569–75.

22.

Loewen

, Lamb

, Clugston

Randomized, double-blind trial of dolasetron versus droperidol for prophylaxis of postoperative nausea and vomiting in patients undergoing TRAM flap breast reconstruction surgery. Ann Plast Surg 2003;51:472–7.

23.

Fujii

, Tanaka

Comparison of granisetron, droperidol, and metoclopramide for prevention of postoperative vomiting in children with a history of motion sickness undergoing tonsillectomy. J Pediatr Surg 2001;36:460–2.

24.

Peixoto

, Peixoto Filho

, Leaes

, Celich

, Barros

. Efficacy of prophylactic droperidol, ondansetron or both in the prevention of postoperative nausea and vomiting in major gynaecological surgery. A prospective, randomized, double-blind clinical trial. Eur J Anaesthesiol 2000;17:611–5.

25.

Reihner

, Grunditz

, Giesecke

, Gustafsson

. Postoperative nausea and vomiting after breast surgery: efficacy of prophylactic ondansetron and droperidol in a randomized placebo-controlled study. Eur J Anaesthesiol 2000;17:197–203.

26.

Fujii

, Tanaka

, Somekawa

Granisetron, droperidol, and metoclopramide for the treatment of established postoperative nausea and vomiting in women undergoing gynecologic surgery. Am J Obstet Gynecol 2000;182:13–6.

27.

Bugedo

, Gonzalez

, Asenjo

Ondansetron and droperidol in the prevention of postoperative nausea and vomiting. Br J Anaesth 1999;83:813–4.

28.

Fujii

, Tanaka

, Kobayashi

Granisetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting after thyroidectomy. Laryngoscope 1999;109:664–7.

29.

Fujii

, Toyooka

, Tanaka

Granisetron–droperidol combination for the prevention of postoperative nausea and vomiting in female patients undergoing breast surgery. Br J Anaesth 1998;81:387–9.

30.

Fujii

, Toyooka

, Tanaka

Prevention of postoperative nausea and vomiting with a combination of granisetron and droperidol. Anesth Analg 1998;86:613–6.

31.

Fujii

, Saitoh

, Tanaka

, Toyooka

Prevention of PONV with granisetron, droperidol or metoclopramide in patients with postoperative emesis. Can J Anaesth 1998;45:153–6.

32.

Fujii

, Toyooka

, Tanaka

Prevention of postoperative nausea and vomiting in female patients during menstruation: comparison of droperidol, metoclopramide and granisetron. Br J Anaesth 1998;80:248–9.

33.

Koivuranta

, Laara

, Ranta

, Ravaska

, Alahuhta

Comparison of ondansetron and droperidol in the prevention of postoperative nausea and vomiting after laparoscopic surgery in women. A randomised, double-blind, placebo-controlled trial. Acta Anaesthesiol Scand 1997;41:1273–9.

34.

Fujii

, Tanaka

, Toyooka

The effects of dexamethasone on antiemetics in female patients undergoing gynecologic surgery. Anesth Analg 1997;85:913–7.

35.

Alexander

, Lovell

, Seingry

, Jones

. Comparison of ondansetron and droperidol in reducing postoperative nausea and vomiting associated with patient-controlled analgesia. Anaesthesia 1995;50:1086–8.

36.

Paech

, Pavy

, Evans

. Single-dose prophylaxis for postoperative nausea and vomiting after major abdominal surgery: ondansetron versus droperidol. Anaesth Intensive Care 1995;23:548–54.

37.

Fujii

, Tanaka

, Toyooka

Prevention of postoperative nausea and vomiting with granisetron: a randomized, double-blind comparison with droperidol. Can J Anaesth 1995;42:852–6.

38.

Gan

, Collis

, Hetreed

Double-blind comparison of ondansetron, droperidol and saline in the prevention of postoperative nausea and vomiting. Br J Anaesth 1994;72:544–7.

39.

Wang

, Tzeng

, Ho

, Chen

, Chu

, So

. The prophylactic effect of tropisetron on epidural morphine-related nausea and vomiting: a comparison of dexamethasone with saline. Anesth Analg 2002;94:749–53.

40.

Abou Zeid

, Al Gahamdi

, Abdul-Hadi

Dolasetron decreases postoperative nausea and vomiting after breast surgery. Breast J 2002;8:216–21.

41.

Janknegt

, Pinckaers

, Rohof

. Double-blind comparative study of droperidol, granisetron and granisetron plus dexamethasone as prophylactic anti-emetic therapy in patients undergoing abdominal, gynaecological, breast or otolaryngological surgery. Anaesthesia 1999;54:1059–68.

42.

Lopez-Olaondo

, Carrascosa

, Pueyo

, Monedero

, Busto

, Saez

Combination of ondansetron and dexamethasone in the prophylaxis of postoperative nausea and vomiting. Br J Anaesth 1996;76:835–40.

43.

Fujii

, Tanaka

, Toyooka

Granisetron–dexamethasone combination reduces postoperative nausea and vomiting. Can J Anaesth 1995;42:387–90.

44.

Awad

, Murphy

, Stack

, Swanton

, Meeke

, Shorten

. A comparison of the effects of droperidol and the combination of droperidol and ondansetron on postoperative nausea and vomiting for patients undergoing laparoscopic cholecystectomy. J Clin Anesth 2002;14:481–5.

45.

McKenzie

, Riley

, Tantisira

, Hamilton

. Effect of propofol for induction and ondansetron with or without dexamethasone for the prevention of nausea and vomiting after major gynecologic surgery. J Clin Anesth 1997;9:15–20.

46.

Holt

, Rask

, Coulthard

. Tropisetron plus dexamethasone is more effective than tropisetron alone for the prevention of postoperative nausea and vomiting in children undergoing tonsillectomy. Paediatr Anaesth 2000;10:181–8.

47.

Fujii

, Tanaka

, Kobayashi

Granisetron/dexamethasone combination for the prevention of postoperative nausea and vomiting after thyroidectomy. Anaesth Intensive Care 2000;28:266–9.

48.

Fujii

, Tanaka

, Toyooka

Prophylactic antiemetic therapy with granisetron-dexamethasone combination in women undergoing breast surgery. Acta Anaesthesiol Scand 1998;42:1038–42.

49.

D'angelo

, Philip

, Gan

. A randomized, double-blind, dose-ranging, pilot study of intravenous granisetron in the prevention of postoperative nausea and vomiting in patients abdominal hysterectomy. Eur J Anaesthesiol 2005;22:774–9.

50.

Gan

, Coop

, Philip

. A randomized, double-blind study of granisetron plus dexamethasone versus ondansetron plus dexamethasone to prevent postoperative nausea and vomiting in patients undergoing abdominal hysterectomy. Anesth Analg 2005;101:1323–9.